Next Article in Journal
Exploring Staff Perceptions of the Management of Clinical Trials and Its Impact on Enhancing Health Service Delivery
Previous Article in Journal
Does Hospital–Physician Integration Improve Hospital Performance? Results from a USA Longitudinal Study
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Perspective

Revolutionizing Patient Safety: The Economic and Clinical Impact of Artificial Intelligence in Hospitals

Medicine Department, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí I3PT, 08208 Sabadell, Spain
Hospitals 2024, 1(2), 185-194; https://doi.org/10.3390/hospitals1020015
Submission received: 11 September 2024 / Revised: 27 November 2024 / Accepted: 3 December 2024 / Published: 12 December 2024
(This article belongs to the Special Issue AI in Hospitals: Present and Future)

Abstract

:
Artificial intelligence (AI) has emerged as a transformative force in enhancing patient safety within hospital settings. This perspective explores the various applications of AI in improving patient outcomes, including early warning systems, predictive analytics, process automation, and personalized treatment. We also highlight the economic benefits associated with AI implementation, such as cost savings through reduced adverse events and improved operational efficiency. Moreover, the perspective addresses how AI can enhance pharmacological treatments, optimize diagnostic testing, and mitigate hospital-acquired infections. Despite the promising advancements, challenges related to data quality, ethical concerns, and clinical integration remain. Future research directions are proposed to address these challenges and harness the full potential of AI in healthcare.

1. Introduction

Ensuring patient safety is one of the foremost priorities in healthcare, particularly within hospital settings, where the high-risk nature of complex care processes poses significant challenges. Patients in hospitals frequently require coordinated and multidisciplinary interventions, often involving various medications, medical devices, and diagnostic procedures that increase the potential for adverse events. In recent years, advancements in artificial intelligence (AI) have provided healthcare providers with new tools to reduce these risks by improving the monitoring, diagnosis, prediction, and management of patient conditions. By processing vast amounts of data, AI technologies such as machine learning algorithms, predictive analytics, and natural language processing have the potential to identify patterns and trends that are difficult to discern through traditional clinical methods. This perspective provides a comprehensive exploration of how AI applications contribute to enhancing patient safety in healthcare environments, focusing on their clinical benefits, economic advantages, and operational efficiency.
The integration of AI in healthcare not only improves patient safety but also provides economic benefits by reducing costs associated with adverse events, optimizing resource allocation, and increasing workflow efficiency. These financial savings are significant in a sector where cost pressures are increasing due to factors such as rising demand, constrained resources, and stringent regulatory requirements. However, as AI systems become more embedded within clinical workflows, it is critical to address ethical and operational challenges, such as data privacy, integration into clinical settings, and maintaining clinical judgment alongside AI recommendations. This perspective will cover these issues, exploring the opportunities and challenges posed by AI’s integration in healthcare.

2. Applications of Artificial Intelligence in Patient Safety

2.1. Early Warning Systems

AI-powered early warning systems (EWSs) have emerged as one of the most promising applications of AI in enhancing patient safety. These systems continuously monitor patient data, including vital signs, laboratory results, and medication records, using sophisticated algorithms to detect early signs of patient deterioration. This is particularly crucial for identifying life-threatening conditions such as sepsis, respiratory failure, and cardiac arrest. The early detection and notification provided by EWSs allow healthcare professionals to intervene more quickly, which has been shown to improve patient outcomes significantly [1,2].
For example, AI-driven models for sepsis detection are now being implemented in hospitals worldwide. Sepsis is a leading cause of mortality in intensive care units (ICUs) and general wards alike, with outcomes heavily dependent on timely intervention. Traditional methods of identifying sepsis rely on periodic monitoring of vital signs and laboratory values, which can miss the early, subtle signs of the condition. AI-driven EWS models, on the other hand, can detect early warning signs hours before clinical symptoms become evident, enabling prompt intervention. Studies show that AI-based EWSs for sepsis can reduce mortality rates significantly, lower ICU admissions, and reduce the length of hospital stays [3,4]. The deployment of these systems has resulted in fewer critical incidents, reinforcing their value as tools for proactive patient care [5,6].
Beyond sepsis, EWSs powered by AI can detect early signs of stroke, acute kidney injury, and post-surgical complications, making these systems useful across various hospital departments. In particular, AI models used in stroke care have demonstrated potential for identifying minor signs of stroke from data patterns that are often missed by clinicians in busy settings. This early intervention allows for the activation of stroke protocols and timely treatment, which can significantly impact patient recovery and reduce disability rates.

2.2. Predictive Analytics

Predictive analytics, driven by AI algorithms, enables the anticipation of adverse events and complications, which is essential for pre-emptive care planning. By analyzing historical and real-time data, AI models can forecast the likelihood of complications such as infections, organ failure, and bleeding, allowing clinicians to adjust care plans accordingly. For example, predictive models in perioperative care are used to identify patients at higher risk of developing acute respiratory distress syndrome (ARDS) following surgery. This allows clinicians to allocate resources and implement preventive measures to reduce the incidence and severity of ARDS, which is associated with high morbidity and mortality [7,8].
In managing chronic diseases, predictive analytics has shown particular promise. Chronic conditions such as diabetes, hypertension, and chronic obstructive pulmonary disease (COPD) often lead to complications when patients are hospitalized. AI can help monitor patients with these conditions by analyzing continuous data from wearables and monitoring devices to detect instability in real time. For example, in diabetic patients, predictive models can anticipate glycemic fluctuations, allowing providers to proactively adjust insulin therapy or dietary recommendations. Similarly, predictive models for COPD patients can help detect early signs of exacerbations, potentially preventing hospitalizations through early outpatient interventions. By identifying high-risk patients, hospitals can prioritize resources for those most in need and reduce avoidable admissions and ICU utilization [9,10]. This capability not only improves patient outcomes but also offers substantial cost savings by reducing the frequency of emergency interventions and minimizing ICU admissions [11,12].

2.3. Process Automation

AI-driven automation has made significant strides in healthcare, offering the potential to improve safety, efficiency, and accuracy across a range of clinical processes. Automated systems for medication administration, order processing, and documentation enhance patient safety by reducing the likelihood of human errors. For instance, errors related to medication administration—such as incorrect dosing, wrong timing, or administering medications to the wrong patient—are a significant concern in hospitals. AI-driven systems can track medication administration in real time, cross-reference patient data, and alert healthcare providers to potential issues, thereby reducing the risk of adverse drug events [13,14].
One example of successful AI-driven automation is the use of smart IV infusion pumps, which can precisely control the dosage of medications being delivered to patients, automatically adjusting the infusion rate based on real-time monitoring. These systems have proven effective in reducing dosage errors and minimizing risks associated with complex medication regimens. Similarly, automated order entry systems reduce the likelihood of transcription errors by allowing clinicians to input orders directly into the electronic health record (EHR) system, which can be cross-checked for accuracy and potential contraindications using AI algorithms [15,16].
Automation also streamlines clinical documentation, which is often a time-consuming task for healthcare providers. Automated documentation systems capture patient information during clinical interactions, accurately recording it in the EHR without requiring manual input. This allows clinicians to focus more on direct patient care, ultimately improving efficiency and reducing the likelihood of documentation errors. Additionally, automation can prioritize patient cases based on acuity, ensuring that high-risk patients receive timely care. AI-enabled triage systems are particularly beneficial in emergency departments (EDs), where rapid and accurate triage is crucial for effective patient management [17,18].

2.4. Personalized Treatment

One of AI’s most impactful contributions to patient safety is in the area of personalized treatment. By analyzing vast amounts of patient data, including genetic, demographic, and clinical information, AI models can identify unique patient characteristics that influence treatment responses. This allows healthcare providers to tailor interventions to individual needs, reducing the risks of adverse drug reactions and ineffective treatments. For instance, pharmacogenomic AI models can help determine optimal drug dosages by analyzing a patient’s genetic profile, minimizing the risk of over- or under-dosing and reducing the likelihood of adverse drug reactions [19,20].
Personalized treatment is not limited to medication dosing. AI is being used in oncology to customize chemotherapy regimens based on genetic markers that indicate how specific tumor types will respond to various therapies. This precision helps reduce toxicity and enhance the efficacy of cancer treatments, improving patient outcomes and minimizing treatment-related complications [21,22]. AI also plays a significant role in tailoring interventions for patients with mental health disorders by analyzing a patient’s clinical history, genetic background, and lifestyle factors to develop personalized treatment plans that optimize therapeutic outcomes. This approach helps avoid the trial-and-error process commonly associated with mental health treatment, thus improving adherence and reducing hospital readmissions [23,24].

3. Economic Benefits of AI in Patient Safety

3.1. Cost Savings from Reduced Adverse Events

One of the most significant financial impacts of AI in healthcare is its potential to reduce costs by preventing adverse events. Severe adverse events, such as sepsis, organ failure, or hospital-acquired infections (HAIs), often require extensive resources and can lead to prolonged ICU stays, increasing treatment costs substantially. By detecting risks early, AI helps prevent the escalation of these conditions, reducing the need for expensive interventions [25,26]. For instance, AI models used in sepsis prediction have shown the potential to reduce costs associated with ICU admissions and long hospital stays by enabling early intervention. Studies indicate that hospitals implementing AI-driven EWSs for sepsis detection experience lower healthcare costs due to fewer ICU admissions and shorter patient stays, as well as a reduction in the use of high-cost interventions [27,28].
AI also mitigates legal liabilities associated with adverse events, as hospitals can demonstrate that they have implemented advanced safety systems to monitor patients continuously. Preventing critical incidents not only enhances patient safety but also lowers potential legal costs associated with malpractice cases, a significant concern in high-risk hospital environments.

3.2. Improved Operational Efficiency

AI contributes to operational efficiency by automating routine tasks, supporting data-driven decision-making, and optimizing resource allocation. By reducing the amount of time healthcare providers spend on repetitive tasks such as data entry, scheduling, and documentation, AI systems free up more time for direct patient care, thereby improving productivity and reducing labor costs [29,30]. Automation tools, such as AI-driven billing and coding systems, streamline administrative processes by ensuring accurate documentation and compliance with billing regulations. This results in faster claim processing, fewer denied claims, and overall reduction in administrative costs.
AI also supports optimized resource management through predictive analytics that anticipate high-demand periods and adjust staffing levels accordingly. For example, in emergency departments, predictive models forecast patient inflow and assist in scheduling staff during peak times to ensure adequate coverage. These efficiencies enhance patient satisfaction by reducing wait times, improving service quality, and ensuring that clinicians are not overburdened during high-demand periods [31,32].

3.3. Enhanced Resource Utilization

Optimizing resource utilization is essential for maintaining cost-effective operations in healthcare settings. AI assists hospitals in efficiently utilizing resources by predicting patient needs, managing bed occupancy, and forecasting staffing requirements. Predictive analytics models enable hospitals to allocate resources more precisely, such as ensuring that beds are available for patients at high risk of ICU transfer. Additionally, AI-driven resource management systems provide insights into supply chain requirements, allowing hospitals to maintain optimal stock levels of medications, personal protective equipment, and medical devices. This just-in-time approach to resource management reduces waste and prevents supply shortages that could impact patient care [33,34].
Moreover, AI systems enhance resource utilization by identifying patients who may benefit from alternative care settings, such as outpatient care or home health services, rather than inpatient hospitalization. For instance, AI can analyze a patient’s risk profile and recommend the most appropriate post-discharge plan, reducing readmission rates and optimizing bed capacity for new admissions. This efficient allocation of resources supports overall patient safety and reduces operational costs [35,36].

4. Impact on Pharmacological Treatments, Diagnostic Testing, and Nosocomial Infections

4.1. Pharmacological Treatments

AI plays a transformative role in optimizing pharmacological treatments, particularly by enabling personalized dosing and reducing the risk of adverse drug reactions. Pharmacogenomics, the study of how genes affect a person’s response to drugs, has increasingly become integrated with AI technology to tailor drug prescriptions based on genetic profiles. This approach allows AI to provide clinicians with insights into optimal medication types, dosages, and potential interactions specific to each patient [37,38]. Traditional methods of determining medication dosage are largely based on population averages and may not always align with individual patient needs, increasing the risk of adverse reactions or ineffective treatment.
With AI, real-time data analysis can track how individual patients metabolize drugs, alerting clinicians if a patient is at risk of an adverse reaction based on metabolic speed or interaction with other medications. This precision has proven especially valuable in oncology, where patients undergoing chemotherapy benefit from targeted dosing that minimizes toxicity while maximizing therapeutic effects [39,40]. AI’s role in personalized medication has also proven crucial in mental health treatment, where AI-driven systems analyze patient data to predict likely responses to antidepressants and antipsychotics, reducing the trial-and-error process that often accompanies treatment adjustments.

4.2. Diagnostic Testing

Diagnostic testing is another domain where AI-driven solutions significantly enhance patient safety. AI algorithms, particularly machine learning models, can analyze complex diagnostic images and identify abnormalities with accuracy comparable to, or sometimes even exceeding, that of human specialists. For instance, AI applications in radiology use image recognition algorithms to detect signs of lung nodules, bone fractures, and cardiovascular anomalies from X-rays, CT scans, and MRIs. The implementation of AI in diagnostic imaging not only improves accuracy but also reduces the time required to interpret results, allowing for faster diagnosis and intervention [41,42].
One of the major benefits of AI in diagnostics is its ability to catch early signs of diseases that might otherwise be overlooked in initial reviews, especially in high-pressure settings such as emergency departments. AI systems in radiology can highlight areas of interest in images, drawing the attention of radiologists to potential abnormalities that require further investigation. For example, in mammography, AI models are being used to detect early-stage breast cancer, with studies showing that these models can reduce false negatives and improve the early detection rates of cancers that are more challenging to detect [43,44]. Such advancements ultimately lead to timely treatments, reducing the need for more extensive interventions that would have been necessary had the disease progressed further.

4.3. Nosocomial Infections

Nosocomial infections, or hospital-acquired infections (HAIs), pose a significant risk to patient safety, especially in ICUs and surgical units where patients are vulnerable to infections due to compromised immunity or invasive procedures. AI-driven systems help prevent and manage HAIs by analyzing patient data and identifying those at elevated risk. For instance, predictive models can assess risk factors for infections like pneumonia, surgical site infections, and Clostridioides difficile infections, providing alerts to clinicians when intervention is needed. By enabling early detection, these models help mitigate the spread of infections and reduce associated healthcare costs [45,46].
AI has also contributed to infection control through its role in antimicrobial stewardship. In hospitals, overuse of antibiotics is a common issue, often resulting in antibiotic resistance. AI models analyze data on infection trends, patient demographics, and pathogen resistance profiles, guiding appropriate antibiotic use. This targeted approach to antibiotic prescription has proven effective in reducing cases of antimicrobial resistance, improving patient outcomes, and ultimately curbing healthcare costs [47,48]. Moreover, AI tools monitor compliance with infection control measures such as hand hygiene, room sanitation, and equipment sterilization. This automated monitoring ensures that infection control protocols are adhered to consistently, thereby reducing HAIs and enhancing overall patient safety.

5. Challenges and Limitations

While the benefits of AI in healthcare are substantial, the technology also faces several challenges and limitations that impact its full integration and effectiveness.

5.1. Data Quality and Availability

The effectiveness of AI in healthcare largely depends on the availability of high-quality, comprehensive data. Inaccurate or incomplete data can lead to erroneous predictions and unreliable decision-making, which may compromise patient safety. Many healthcare organizations still face challenges related to data standardization, interoperability, and data entry errors, limiting the utility of AI tools. The lack of integrated data systems across departments and institutions further complicates the deployment of AI solutions, as these systems often rely on information from multiple sources to make accurate predictions and recommendations [49,50]. To maximize the effectiveness of AI, healthcare providers must invest in standardized data collection and integration practices that ensure data completeness and accuracy [51,52].

5.2. Ethical and Privacy Concerns

AI applications in healthcare rely heavily on the use of sensitive patient data, raising significant ethical and privacy concerns. Patient data must be handled with utmost care to protect confidentiality, ensure compliance with regulations, and maintain public trust. In many cases, data used for AI training purposes are subject to strict regulatory controls, particularly with laws like the Health Insurance Portability and Accountability Act (HIPAA) in the United States, which mandate the secure handling of patient information [53,54]. To address these challenges, healthcare organizations must establish robust data protection frameworks, and AI developers should prioritize transparency in their algorithms to avoid potential biases and ethical dilemmas associated with automated decision-making [55,56].

5.3. Clinical Integration and Acceptance

The integration of AI into clinical workflows is another major challenge, as healthcare professionals may resist adopting new technologies without sufficient training or evidence of value. Successful implementation of AI systems requires a comprehensive approach to change management, including training programs that highlight the practical benefits of AI tools. Healthcare providers must feel confident that AI will not replace their expertise but will serve as an adjunct to enhance their decision-making capabilities [57,58]. Furthermore, demonstrating the efficacy of AI tools through clinical trials and studies is essential in increasing acceptance among healthcare professionals.

5.4. Dependence and Error Risks

The risk of over-reliance on AI systems is a concern, as it could lead to diminished clinical judgment and potential patient harm if an AI system fails or provides inaccurate information. AI models, particularly those based on machine learning, are susceptible to errors due to the limitations of their training data or unintended biases within the algorithms. Healthcare providers must strike a balance between utilizing AI recommendations and exercising clinical judgment. Maintaining human oversight and establishing protocols for verifying AI-generated recommendations are crucial steps for minimizing risk and ensuring effective patient care [59,60].

6. Conclusions

Artificial intelligence offers substantial benefits in healthcare, particularly in enhancing patient safety by improving monitoring, predictive capabilities, and personalized treatment approaches. The economic advantages associated with AI, such as reduced adverse events, increased operational efficiency, and optimized resource utilization, underscore its potential impact on modern healthcare systems. AI’s role in optimizing pharmacological treatments, refining diagnostic testing, and controlling nosocomial infections further highlights its value. Nevertheless, challenges related to data quality, ethical concerns, and clinical integration must be addressed to maximize AI’s potential.
For AI to fulfill its promise in healthcare, ongoing research, collaboration, and commitment to ethical standards are essential. Implementing policies that protect patient privacy, ensure data accuracy, and support clinical training will pave the way for responsible AI integration. As healthcare continues to evolve with the adoption of AI, the potential to enhance patient safety and improve clinical outcomes will increase, benefiting both healthcare providers and patients alike.

7. Future Directions

Future research should focus on the following areas to further advance the integration of AI in healthcare:

7.1. Enhancing Data Quality and Interoperability

To maximize the potential of AI in healthcare, there is a pressing need to develop standardized methods for data collection, ensuring accuracy and consistency across diverse health systems. Research should focus on creating interoperable data-sharing frameworks that facilitate seamless integration across different healthcare platforms and systems. Interoperable data can improve the accuracy of AI models by providing access to comprehensive datasets, thus enabling more reliable predictions and recommendations [61,62].

7.2. Addressing Ethical and Privacy Issues

Establishing clear guidelines for AI ethics and privacy is essential for the responsible implementation of AI in healthcare. Researchers and policymakers must collaborate to create policies that ensure patient data are handled with care, protecting confidentiality and preventing potential biases in AI algorithms. Future work should explore methods for algorithm transparency, enabling healthcare providers to understand and verify AI-driven decisions in patient care [63,64].

7.3. Facilitating Clinical Adoption

Clinical adoption of AI requires extensive training and education for healthcare providers. Future research should focus on developing training programs that demonstrate the value of AI tools and improve healthcare professionals’ understanding of AI technology. These programs should emphasize that AI serves as a support tool, enhancing clinical decision-making rather than replacing it. Practical, evidence-based demonstrations of AI’s effectiveness in real-world clinical scenarios will also be key to fostering acceptance and utilization [65,66].

7.4. Longitudinal Impact Studies

Long-term studies are needed to assess the impact of AI on patient safety, clinical outcomes, and healthcare costs. These studies should investigate the effects of AI on various patient populations, care settings, and health conditions to determine where AI interventions are most beneficial. Longitudinal impact studies will also provide insights into potential unintended consequences of AI deployment, helping healthcare providers make informed decisions regarding the use of AI technologies [67,68].

Funding

This research received no external funding.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The author declares no conflicts of interest.

References

  1. Yang, J.; Hao, S.; Huang, J.; Chen, T.; Liu, R.; Zhang, P.; Feng, M.; He, Y.; Xiao, W.; Hong, Y.; et al. The application of artificial intelligence in the management of sepsis. Med. Rev. 2023, 3, 369–380. [Google Scholar] [CrossRef] [PubMed]
  2. Muralitharan, S.; Nelson, W.; Di, S.; McGillion, M.; Devereaux, P.J.; Barr, N.G.; Petch, J. Machine Learning-Based Early Warning Systems for Clinical Deterioration: Systematic Scoping Review. J. Med. Internet Res. 2021, 23, e25187. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  3. Lim, L.; Gim, U.; Cho, K.; Yoo, D.; Ryu, H.G.; Lee, H.C. Real-time machine learning model to predict short-term mortality in critically ill patients: Development and international validation. Crit. Care 2024, 28, 76. [Google Scholar] [CrossRef] [PubMed]
  4. Meckawy, R.; Stuckler, D.; Mehta, A.; Al-Ahdal, T.; Doebbeling, B.N. Effectiveness of early warning systems in the detection of infectious diseases outbreaks: A systematic review. BMC Public Health 2022, 22, 2216. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  5. Veldhuis, L.I.; Woittiez, N.J.C.; Nanayakkara, P.W.B.; Ludikhuize, J. Artificial Intelligence for the Prediction of In-Hospital Clinical Deterioration: A Systematic Review. Crit. Care Explor. 2022, 4, e0744. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  6. Huang, Y.; Talwar, A.; Chatterjee, S.; Aparasu, R.R. Application of machine learning in predicting hospital readmissions: A scoping review of the literature. BMC Med. Res. Methodol. 2021, 21, 96. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  7. Zhang, Z. Predictive analytics in the era of big data: Opportunities and challenges. Ann. Transl. Med. 2020, 8, 68. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  8. Davis, S.; Zhang, J.; Lee, I.; Rezaei, M.; Greiner, R.; McAlister, F.A.; Padwal, R. Effective hospital readmission prediction models using machine-learned features. BMC Health Serv Res 2022, 22, 1415. [Google Scholar] [CrossRef]
  9. Wu, Y.; Li, L.; Xin, B.; Hu, Q.; Dong, X.; Li, Z. Application of machine learning in personalized medicine. Intell. Pharm. 2023, 1, 152–156. [Google Scholar] [CrossRef]
  10. Johnson, K.B.; Wei, W.Q.; Weeraratne, D.; Frisse, M.E.; Misulis, K.; Rhee, K.; Zhao, J.; Snowdon, J.L. Precision Medicine, AI, and the Future of Personalized Health Care. Clin. Transl. Sci. 2021, 14, 86–93. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  11. Aoun, M.; Sandhu, A.K. Understanding the Impact of AI-Driven Automation on the Workflow of Radiologists in Emergency Care Settings. J. Intell. Connect. Emerg. Technol. 2019, 4, 1–15. Available online: https://questsquare.org/index.php/JOUNALICET/article/view/11 (accessed on 1 December 2024).
  12. Dubey, K.; Bhowmik, M.; Pawar, A.; Patil, M.K.; Deshpande, P.A.; Khartad, S.S. Enhancing Operational Efficiency in Healthcare with AI-Powered Management. In Proceedings of the 2023 International Conference on Artificial Intelligence for Innovations in Healthcare Industries (ICAIIHI), Raipur, India, 29–30 December 2023; pp. 1–7. [Google Scholar] [CrossRef]
  13. Johnson, A.; Pollard, T.; Shen, L.; Lehman, L.-W.H.; Feng, M.; Ghassemi, M.; Moody, B.; Szolovits, P.; Celi, L.A.; Mark, R.G. MIMIC-III, a freely accessible critical care database. Sci. Data 2016, 3, 160035. [Google Scholar] [CrossRef] [PubMed]
  14. Alowais, S.A.; Alghamdi, S.S.; Alsuhebany, N.; Alqahtani, T.; Alshaya, A.I.; Almohareb, S.N.; Aldairem, A.; Alrashed, M.; Bin Saleh, K.; Badreldin, H.A.; et al. Revolutionizing healthcare: The role of artificial intelligence in clinical practice. BMC Med. Educ. 2023, 23, 689. [Google Scholar] [CrossRef] [PubMed]
  15. Naik, K.; Goyal, R.K.; Foschini, L.; Chak, C.W.; Thielscher, C.; Zhu, H.; Lu, J.; Lehár, J.; Pacanoswki, M.A.; Terranova, N.; et al. Current Status and Future Directions: The Application of Artificial Intelligence/Machine Learning for Precision Medicine. Clin. Pharmacol. Ther. 2024, 115, 673–686. [Google Scholar] [CrossRef]
  16. MacEachern, S.J.; Forkert, N.D. Machine learning for precision medicine. Genome 2021, 64, 416–425. [Google Scholar] [CrossRef] [PubMed]
  17. Singareddy, S.; Sn, V.P.; Jaramillo, A.P.; Yasir, M.; Iyer, N.; Hussein, S.; Nath, T.S. Artificial Intelligence and Its Role in the Management of Chronic Medical Conditions: A Systematic Review. Cureus 2023, 15, e46066. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  18. Byrne, D.W.; Domenico, H.J.; Moore, R.P. Artificial Intelligence for Improved Patient Outcomes-The Pragmatic Randomized Controlled Trial Is the Secret Sauce. Korean J. Radiol. 2024, 25, 123–125. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  19. Crisafulli, S.; Ciccimarra, F.; Bellitto, C.; Carollo, M.; Carrara, E.; Stagi, L.; Triola, R.; Capuano, A.; Chiamulera, C.; Moretti, U.; et al. Artificial intelligence for optimizing benefits and minimizing risks of pharmacological therapies: Challenges and opportunities. Front. Drug Saf. Regul. 2024, 4, 1356405. [Google Scholar] [CrossRef]
  20. Najjar, R. Redefining Radiology: A Review of Artificial Intelligence Integration in Medical Imaging. Diagnostics 2023, 13, 2760. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  21. Radaelli, D.; Di Maria, S.; Jakovski, Z.; Alempijevic, D.; Al-Habash, I.; Concato, M.; Bolcato, M.; D’Errico, S. Advancing Patient Safety: The Future of Artificial Intelligence in Mitigating Healthcare-Associated Infections: A Systematic Review. Healthcare 2024, 12, 1996. [Google Scholar] [CrossRef]
  22. Arzilli, G.; De Vita, E.; Pasquale, M.; Carloni, L.M.; Pellegrini, M.; Di Giacomo, M.; Esposito, E.; Porretta, A.D.; Rizzo, C. Innovative Techniques for Infection Control and Surveillance in Hospital Settings and Long-Term Care Facilities: A Scoping Review. Antibiotics 2024, 13, 77. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  23. Yang, L.; Lu, S.; Zhou, L. The Implications of Artificial Intelligence on Infection Prevention and Control: Current Progress and Future Perspectives. China CDC Wkly. 2024, 6, 901–904. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  24. Nguemeleu, E.T.; Beogo, I.; Sia, D.; Kilpatrick, K.; Séguin, C.; Baillot, A.; Jabbour, M.; Parisien, N.; Robins, S.; Boivin, S. Economic analysis of healthcare-associated infection prevention and control interventions in medical and surgical units: Systematic review using a discounting approach. J. Hosp. Infect. 2020, 106, 134–154. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  25. Bates, D.W.; Levine, D.; Syrowatka, A.; Kuznetsova, M.; Craig, K.J.T.; Rui, A.; Jackson, G.P.; Rhee, K. The potential of artificial intelligence to improve patient safety: A scoping review. NPJ Digit. Med. 2021, 4, 54. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  26. Zwerwer, L.R.; van der Pol, S.; Zacharowski, K.; Postma, M.J.; Kloka, J.; Friedrichson, B.; van Asselt, A.D.I. The value of artificial intelligence for the treatment of mechanically ventilated intensive care unit patients: An early health technology assessment. J. Crit. Care 2024, 82, 154802. [Google Scholar] [CrossRef] [PubMed]
  27. Khanna, N.N.; Maindarkar, M.A.; Viswanathan, V.; Fernandes, J.F.E.; Paul, S.; Bhagawati, M.; Ahluwalia, P.; Ruzsa, Z.; Sharma, A.; Kolluri, R.; et al. Economics of Artificial Intelligence in Healthcare: Diagnosis vs. Treatment. Healthcare 2022, 10, 2493. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  28. Khosravi, M.; Zare, Z.; Mojtabaeian, S.M.; Izadi, R. Artificial Intelligence and Decision-Making in Healthcare: A Thematic Analysis of a Systematic Review of Reviews. Health Serv. Res. Manag. Epidemiol. 2024, 11, 23333928241234863. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  29. Ramezani, M.; Takian, A.; Bakhtiari, A.; Rabiee, H.R.; Fazaeli, A.A.; Sazgarnejad, S. The application of artificial intelligence in health financing: A scoping review. Cost Eff. Resour. Alloc. 2023, 21, 83. [Google Scholar] [CrossRef]
  30. Davenport, T.; Kalakota, R. The potential for artificial intelligence in healthcare. Future Healthc. J. 2019, 6, 94–98. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  31. Rahimi, A.K.; Pienaar, O.; Ghadimi, M.; Canfell, O.J.; Pole, J.D.; Shrapnel, S.; van der Vegt, A.H.; Sullivan, C. Implementing AI in Hospitals to Achieve a Learning Health System: Systematic Review of Current Enablers and Barriers. J. Med. Internet Res. 2024, 26, e49655. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  32. Bhagat, S.V.; Kanyal, D. Navigating the Future: The Transformative Impact of Artificial Intelligence on Hospital Management—A Comprehensive Review. Cureus 2024, 16, e54518. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  33. Ebugosi, Q.-M.; Olaboye, J. Optimizing healthcare resource allocation through data-driven demographic and psychographic analysis. Comput. Sci. IT Res. J. 2024, 5, 1488–1504. [Google Scholar] [CrossRef]
  34. Sheng, J.Q.; Hu, P.J.; Liu, X.; Huang, T.S.; Chen, Y.H. Predictive Analytics for Care and Management of Patients with Acute Diseases: Deep Learning-Based Method to Predict Crucial Complication Phenotypes. J. Med. Internet Res. 2021, 23, e18372. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  35. Lindroth, H.; Nalaie, K.; Raghu, R.; Ayala, I.N.; Busch, C.; Bhattacharyya, A.; Franco, P.M.; Diedrich, D.A.; Pickering, B.W.; Herasevich, V. Applied Artificial Intelligence in Healthcare: A Review of Computer Vision Technology Application in Hospital Settings. J. Imaging 2024, 10, 81. [Google Scholar] [CrossRef]
  36. Francis, J.; Varghese, J.; Thomas, A. Impact of artificial intelligence on healthcare. Int. J. Adv. Med. 2023, 10, 10. [Google Scholar] [CrossRef]
  37. Vora, L.K.; Gholap, A.D.; Jetha, K.; Thakur, R.R.S.; Solanki, H.K.; Chavda, V.P. Artificial Intelligence in Pharmaceutical Technology and Drug Delivery Design. Pharmaceutics 2023, 15, 1916. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  38. Ali, K.A.; Mohin, S.; Mondal, P.; Goswami, S.; Ghosh, S.; Choudhuri, S. Influence of artificial intelligence in modern pharmaceutical formulation and drug development. Future J. Pharm. Sci. 2024, 10, 53. [Google Scholar] [CrossRef]
  39. Danysz, K.; Cicirello, S.; Mingle, E.; Assuncao, B.; Tetarenko, N.; Mockute, R.; Abatemarco, D.; Widdowson, M.; Desai, S. Artificial Intelligence and the Future of the Drug Safety Professional. Drug Saf. 2019, 42, 491–497. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  40. Carini, C.; Seyhan, A.A. Tribulations and future opportunities for artificial intelligence in precision medicine. J. Transl. Med. 2024, 22, 411. [Google Scholar] [CrossRef]
  41. Meşe, İ.; Taşlıçay, C.A.; Kuzan, B.N.; Kuzan, T.Y.; Sivrioğlu, A.K. Educating the next generation of radiologists: A comparative report of ChatGPT and e-learning resources. Diagn. Interv. Radiol. 2024, 30, 163–174. [Google Scholar] [CrossRef]
  42. Brady, A.P.; Allen, B.; Chong, J.; Kotter, E.; Kottler, N.; Mongan, J.; Oakden-Rayner, L.; dos Santos, D.P.; Tang, A.; Wald, C.; et al. Developing, purchasing, implementing and monitoring AI tools in radiology: Practical considerations. A multi-society statement from the ACR, CAR, ESR, RANZCR & RSNA. Insights Imaging 2024, 15, 16. [Google Scholar] [CrossRef] [PubMed]
  43. Ouanes, K.; Farhah, N. Effectiveness of Artificial Intelligence (AI) in Clinical Decision Support Systems and Care Delivery. J. Med. Syst. 2024, 48, 74. [Google Scholar] [CrossRef] [PubMed]
  44. Wang, H.; Jia, S.; Li, Z.; Duan, Y.; Tao, G.; Zhao, Z. A Comprehensive Review of Artificial Intelligence in Prevention and Treatment of COVID-19 Pandemic. Front. Genet. 2022, 13, 845305. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  45. Baddal, B.; Taner, F.; Ozsahin, D.U. Harnessing of Artificial Intelligence for the Diagnosis and Prevention of Hospital-Acquired Infections: A Systematic Review. Diagnostics 2024, 14, 484. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  46. Zhang, X.; Zhang, D.; Zhang, X.; Zhang, X. Artificial intelligence applications in the diagnosis and treatment of bacterial infections. Front. Microbiol. 2024, 15, 1449844. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  47. Blatnik, P.; Bojnec, Š. Analysis of impact of nosocomial infections on cost of patient hospitalisation. Cent. Eur. J. Public Health 2023, 31, 90–96. [Google Scholar] [CrossRef] [PubMed]
  48. Ranjbar, A.; Ravn, J. Data Quality in Healthcare for the Purpose of Artificial Intelligence: A Case Study on ECG Digitalization. Stud. Health Technol. Inform. 2023, 305, 471–474. [Google Scholar] [CrossRef] [PubMed]
  49. Klooster, I.T.; Kip, H.; van Gemert-Pijnen, L.; Crutzen, R.; Kelders, S. A systematic review on eHealth technology personalization approaches. iScience 2024, 27, 110771. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  50. Karalis, V.D. The Integration of Artificial Intelligence into Clinical Practice. Appl. Biosci. 2024, 3, 14–44. [Google Scholar] [CrossRef]
  51. Petersson, L.; Larsson, I.; Nygren, J.M.; Nilsen, P.; Neher, M.; Reed, J.E.; Tyskbo, D.; Svedberg, P. Challenges to implementing artificial intelligence in healthcare: A qualitative interview study with healthcare leaders in Sweden. BMC Health Serv. Res. 2022, 22, 850. [Google Scholar] [CrossRef]
  52. Kolluri, V. Ethical Considerations in the Use of AI in Healthcare: Discussing the Ethical Dilemmas and Considerations of Implementing AI in Patient Care and Decision-Making Venkateswaranaidu Kolluri. J. Emerg. Technol. Innov. Res. 2024, 11, i330–i335. [Google Scholar]
  53. Murdoch, B. Privacy and artificial intelligence: Challenges for protecting health information in a new era. BMC Med. Ethics 2021, 22, 122. [Google Scholar] [CrossRef] [PubMed]
  54. MacIntyre, M.R.; Cockerill, R.G.; Mirza, O.F.; Appel, J.M. Ethical considerations for the use of artificial intelligence in medical decision-making capacity assessments. Psychiatry Res. 2023, 328, 115466. [Google Scholar] [CrossRef] [PubMed]
  55. Abujaber, A.A.; Nashwan, A.J. Ethical framework for artificial intelligence in healthcare research: A path to integrity. World J. Methodol. 2024, 14, 94071. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  56. Macri, R.; Roberts, S.L. The Use of Artificial Intelligence in Clinical Care: A Values-Based Guide for Shared Decision Making. Curr. Oncol. 2023, 30, 2178–2186. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  57. Ranjbar, A.; Mork, E.W.; Ravn, J.; Brøgger, H.; Myrseth, P.; Østrem, H.P.; Hallock, H. Managing Risk and Quality of AI in Healthcare: Are Hospitals Ready for Implementation? Risk Manag. Healthc. Policy 2024, 17, 877–882. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  58. Choudhury, A.; Asan, O. Role of Artificial Intelligence in Patient Safety Outcomes: Systematic Literature Review. JMIR Med. Inform. 2020, 8, e18599. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  59. Bajwa, J.; Munir, U.; Nori, A.; Williams, B. Artificial intelligence in healthcare: Transforming the practice of medicine. Future Healthc. J. 2021, 8, e188–e194. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  60. Aldoseri, A.; Al-Khalifa, K.N.; Hamouda, A.M. Re-Thinking Data Strategy and Integration for Artificial Intelligence: Concepts, Opportunities, and Challenges. Appl. Sci. 2023, 13, 7082. [Google Scholar] [CrossRef]
  61. Gerke, S.; Minssen, T.; Cohen, G. Ethical and legal challenges of artificial intelligence-driven healthcare. In Artificial Intelligence in Healthcare; Elsevier: Amsterdam, The Netherlands, 2020; pp. 295–336. [Google Scholar] [CrossRef] [PubMed Central]
  62. Yim, D.; Khuntia, J.; Parameswaran, V.; Meyers, A. Preliminary Evidence of the Use of Generative AI in Health Care Clinical Services: Systematic Narrative Review. JMIR Med. Inform. 2024, 12, e52073. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  63. Charow, R.; Jeyakumar, T.; Younus, S.; Dolatabadi, E.; Salhia, M.; Al-Mouaswas, D.; Anderson, M.; Balakumar, S.; Clare, M.; Dhalla, A.; et al. Artificial Intelligence Education Programs for Health Care Professionals: Scoping Review. JMIR Med. Educ. 2021, 7, e31043. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  64. Mukherjee, J.; Sharma, R.; Dutta, P.; Bhunia, B. Artificial intelligence in healthcare: A mastery. Biotechnol Genet Eng Rev. 2024, 40, 1659–1708. [Google Scholar] [CrossRef] [PubMed]
  65. Al Meslamani, A.Z. Beyond implementation: The long-term economic impact of AI in healthcare. J. Med. Econ. 2023, 26, 1566–1569. [Google Scholar] [CrossRef] [PubMed]
  66. Epelde, F. Optimizing Cardiac Rehabilitation in Heart Failure: Comprehensive Insights, Barriers, and Future Strategies. Medicina 2024, 60, 1583. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  67. Caldwell, H.A.T.; Yusuf, J.; Carrea, C.; Conrad, P.; Embrett, M.; Fierlbeck, K.; Hajizadeh, M.; Kirk, S.F.L.; Rothfus, M.; Sampalli, T.; et al. Strategies and indicators to integrate health equity in health service and delivery systems in high-income countries: A scoping review. JBI Evid. Synth. 2024, 22, 949–1070. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
  68. Nadarzynski, T.; Knights, N.; Husbands, D.; Graham, C.A.; Llewellyn, C.D.; Buchanan, T.; Montgomery, I.; Ridge, D. Achieving health equity through conversational AI: A roadmap for design and implementation of inclusive chatbots in healthcare. PLoS Digit. Health 2024, 3, e0000492. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Epelde, F. Revolutionizing Patient Safety: The Economic and Clinical Impact of Artificial Intelligence in Hospitals. Hospitals 2024, 1, 185-194. https://doi.org/10.3390/hospitals1020015

AMA Style

Epelde F. Revolutionizing Patient Safety: The Economic and Clinical Impact of Artificial Intelligence in Hospitals. Hospitals. 2024; 1(2):185-194. https://doi.org/10.3390/hospitals1020015

Chicago/Turabian Style

Epelde, Francisco. 2024. "Revolutionizing Patient Safety: The Economic and Clinical Impact of Artificial Intelligence in Hospitals" Hospitals 1, no. 2: 185-194. https://doi.org/10.3390/hospitals1020015

APA Style

Epelde, F. (2024). Revolutionizing Patient Safety: The Economic and Clinical Impact of Artificial Intelligence in Hospitals. Hospitals, 1(2), 185-194. https://doi.org/10.3390/hospitals1020015

Article Metrics

Back to TopTop